Platelet protective effect of TAK-029, a novel glycoprotein IIb/IIIa antagonist: An in vitro study

Artificial Organs

Volumn 22, Issue 4, 1998, Pages 348-352

  Kawahito, Koji ^a   Fujimura, Akio ^a   Kobayashi, Eiji ^a   Misawa, Yoshio ^a   Fuse, Katsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiopulmonary bypass; Glycoprotein IIb IIIa; Platelet

Indexed keywords

GLYCOPROTEINS;

CARDIOPULMONARY BYPASS; CONTROL GROUPS; GLYCOPROTEIN IIB-IIIA; GLYCOPROTEIN IIB/IIIA RECEPTOR; IN-VITRO; IN-VITRO MODELS; NONPEPTIDE; PROTECTIVE EFFECTS; SHEAR FORCE; VITRO STUDIES;

PLATELETS;

1,3 METHYL 4H [N (4 AMIDINOBENZOYL)GLYCYL] 2 OXO 1,3 PIPERAZINE DIACETIC ACID; 4 (4 AMIDINOBENZOYLGLYCYL) 3 METHOXYCARBONYLMETHYL 2 OXO 1 PIPERAZINEACETIC ACID; BETA THROMBOGLOBULIN; FIBRINOGEN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CIRCULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0031958569     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06050.x     Document Type: Article

References (30)

1. Mohr R, Golan M, Martinowitz U, Rosner E, Goor DA, Ramot B. Effect of cardiac operation on platelets. J Thorac Cardiovasc Surg 1986;92:434-41.
2. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-92.
3. Bick RL. Hemostasis defects associated with cardiac surgery, prosthetic device, and other extracorporeal circuits. Semin Thromb Hemost 1985;11:249-80.
4. Ray MJ, Hawson GA, Just SJ, McLachlan G, O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6.
5. Edmunds LH Jr, Ellison N, Colman RW, Niewiarowski S, Rao AK, Addonizio VP Jr, Stephenson LW, Edie RN. Platelet function during cardiac operation: Comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982;83:805-12.
6. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH Jr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;97:235-9.
7. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
8. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
9. O'Brien JR. Shear-induced platelet aggregation. Lancet 1990; 335:711-3.
10. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Heliums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelet, as well as by exogenous large or unusually large vWF multimers, requires adenosine dephospate, and is resistant to aspirin. Blood 1988;71:1366-74.
11. Longmore DB, Bennett JG, Hoyle PM, Smith MA, Gregory A, Osivand T, Jones WA. Prostacycline administration during cardiopulmonary bypass in man. Lancet 1981;1:800-4.
12. van den Dungen JJ, Karliczek GF, Brenken U, Homan van der Heide JN, Wildevuur CR. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982;83:108-16.
13. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb/IIIa complex. Blood 1988;71: 831-43.
14. Plow EF, Ginsberg MH. Cellular adhesion: GP IIb/IIIa as a prototypic adhesion receptor. Prog Hemost Thromb 1989;9: 117-56.
15. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
16. Dechavanne M, Ffrench M, Pages J, Ffrench P, Boukerche H, Bryon PA, McGregor JL. Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb-IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 1987; 57:106-9.
17. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986;78:340-8.
18. Musial J, Niewiarowski S, Rucinski B, Stewart GJ, Cook JJ, Williams JA, Edmunds LH Jr. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation 1990;82: 261-73.
19. Shigeta O, Gluszko P, Downing SW, Lu W, Niewiarowski S, Edmunds LH Jr. Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin. Circulation 1992;86(Suppl II):398-404.
20. Uthoff K, Zehr KJ, Geerling R, Herskowitz A, Cameron DE, Reitz BA. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding. Circulation 1994;90(Part 2):269-74.
21. Hiramatsu Y, Gikakis N, Anderson HL 3rd, Gorman JH 3rd, Marcinkiewicz C, Gould RJ, Niewiarowski S, Edmunds LH Jr. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons. J Thorac Cardiovasc Surg 1997; 113:182-93.
22. 1 and argatroban. J Pharmacol Exp Ther 1996;277: 502-10.
23. Kawahito K, Mohara J, Misawa Y, Fuse K. Platelet damage caused by the centrifugal pump: In vitro evaluation by measuring the release of α-granule packing proteins. Artif Organs 1997;21:1105-9.
24. Mohara J, Kawahito K, Misawa Y, Fuse K. Evaluation of platelet damage in different centrifugal pumps. Based on measurements of α-granule packing proteins. Artif Organs (submitted).
25. Takami Y, Makinouchi K, Nakazawa T, Benkowski R, Glueck J, Ohara Y, Nosé Y. Hemolytic characteristics of a pivot bearing supported Gyro centrifugal pump (C1E3) simulating various clinical applications. Artif Organs 1996;20: 1042-9.
26. Kawahito K, Nosé Y. Hemolysis in different centrifugal pumps. Artif Organs 1997;21:323-6.
27. Teoh KH, Christakis GT, Weisel RD, Wong PY, Mee AV, Ivanov J, Madonik MM, Levitt DS, Reilly PA, Rosenfeld JM, Glynn MFX. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988;96:332-41.
28. Kappa JR, Fisher CA, Todd B, Stenach N, Bell P, Campbell F, Ellison N, Addonizio VPP. Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg 1990;49:714-23.
29. De Prost D, Barbier-Boehm G, Hazebroucq J, Ibrahim H, Bielsky MC, Hvass U, Lacombe C, Francais JL, Desmonts JM. Desmopressin has no beneficial effect on excessive post-operative bleeding or blood product requirements associated with cardiopulmonary bypass. Blood 1992;68:106-10.
30. Addonizio VP Jr, Fisher CA, Jenkins BK, Strauss JF, Musial JF, Edmunds LH Jr. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation. J Thorac Cardiovasc Surg 1985;89:926-33.